Kemin Receives ANVISA Approval for Sale of ZeaONE

635899182152549903eyehealth.jpg

01 Feb 2016 --- ANVISA, Brazil’s national Health Surveillance Agency, has approved for sale its product, ZeaONE Zeaxanthin - a naturally sourced dietary free-form of zeaxanthin from marigolds. 

ZeaONE is a dietary free-form zeaxanthin ingredient naturally sourced from marigolds produced by Kemin. Zeaxanthin, like lutein, is proven to act as a protective antioxidant and filter of blue light in the eye and skin. Scientific evidence shows that supplementing diets with lutein and zeaxanthin daily:
• helps keep skin healthy,
• improves visual performance, and
• reduces the risk of certain eye conditions.

Latest findings from the US National Eye Institute’s second age-related eye disease study (AREDS2) report that 2mg of zeaxanthin, along with 10mg of FloraGLO Lutein, can slow the progression of age-related macular degeneration.

This approval allows Kemin, owner of FloraGLO Lutein brand, to immediately begin marketing the product in Brazil: “Now Brazilian customers will be offered easy-to-use, convenient formulations that combine the two complementary ingredients, lutein and zeaxanthin” Kemin told NutritionInsight

The zeaxanthin in ZeaONE comes from a patented line of marigolds exclusively licensed to Kemin, and naturally contains high levels of the carotenoid zeaxanthin (3R, 3’R zeaxanthin) found in the red and orange fruits and vegetables in our diet. 

ZeaONE is commercially available under DSM’s brand OPTISHARP Natural.

RELATED ARTICLES
Homepicture

EFSA rejects Unilever black tea health claim

18 Jan 2018 The European Food and Safety Authority (EFSA) ...

Homepicture

Bayn Europe sets up subsidiary in China for sugar reduction

15 Jan 2018 Bayn Europe AB has signed a joint venture ...

Homepicture

EFSA more than doubles safe levels for 3-MCPD in vegetable oils and food

15 Jan 2018 The European Food Safety Authority (EFSA) has ...